Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Trivedi, Meghna ^a   Lokhandwala, Mustafa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

D1A receptors; Dopamine; G protein coupled receptors; Hyperphosphorylation; Kidney; Obesity

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCOSE; INSULIN; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 22344448639     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00362.2004     Document Type: Article

References (41)

1. Adler A. Obesity and target organ damage: diabetes. Int J Obes Relat Metab Disord 26, Suppl 4: S11-S14, 2002.
2. Akhter SA, Eckhart AD, Rockman HA, Shotwell K, Lefkowitz RJ, and Koch WJ. In vivo inhibition of elevated myocardial β-adrenergic receptor kinase activity in hybrid transgenic mice restores normal β-adrenergic signaling and function. Circulation 100: 648-653, 1999.
3. 1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97: 2283-2288, 1996.
4. 1A receptors in proximal tubules of old Fischer 344 rats. Am J Physiol Renal Physiol 283: F350-F355, 2002.
5. Bohm SK, Grady EF, and Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 322: 1-18, 1997.
6. Bossenmaier B, Mosthaf L, Mischak H, Ullrich A, and Haring HU. Protein kinase C isoforms β1 and β2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 40: 863-866, 1997.
7. DeChatel R, Wiedmann P, Flammer J, Zeigler WH, Beretta-Piccoli C, Vetter W, and Reubi FC. Sodium, renin, aldosterone, catecholamines and blood pressure in diabetes mellitus. Kidney Int 12: 412-421, 1977.
8. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, and Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99: 3872-3877, 2002.
9. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24, 2001.
10. Gerges NZ, Aleisa AM, Schwarz LA, and Alkadhi KA. Chronic psychosocial stress decreases calcineurin in the dentate gyrus: a possible mechanism for preservation of early 1tp. Neuroscience 117: 869-874, 2003.
11. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 10: 49S-55S, 1997.
12. Hata JA and Koch WJ. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease. Mol Interv 3: 264-272, 2003.
13. Hegde SS, Jadhav AL, and Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 13: 828-834, 1989.
14. Hussein T, Becker M, Beheray S, and Lokhandwala MF. Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats. Clin Exp Hypertens 23: 591-601, 2001.
15. Hussein T, Beheray SA, and Lokhandwala MF. Defective dopamine receptor function in proximal tubules of obese Zucker rats. Hypertension 34: 1091-1096, 1999.
16. Hussein T and Lokhendwele MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134-142, 2003.
17. Inoguchi T, Sonte T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, and Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14: S227-S232, 2003.
18. Jiang G, Dallas-Yang Q, Li Z, Szalkowski D, Liu F, Shen X, Wu M, Zhou G, Doebber T, Berger J, Moller DE, and Zhang BB. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARγ agonists. Diabetes 51: 2412-2419, 2002.
19. 1 dopamine receptors couple to multiple Gα proteins in different brain regions. J Neurochem 78: 981-990, 2001.
20. Jose PA, Eisner GM, and Felder RA. Dopamine receptor-coupling defect in hypertension. Curr Hypertens Rep 4: 237-244, 2002.
21. Jose PA, Eisner GM, and Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182, 1998.
22. Kansra V, Hussain T, and Lokhandwala MF. Alterations in dopamine DA1 receptor and G proteins in renal proximal tubules of old rats. Am J Physiol Renal Physiol 273: F53-F59, 1997.
23. Kikuchi K, Iimura O, Yamaji I, Shibata S, Nishimura M, Aoki K, Nozawa A, Hasegawa T, Honma C, and Kobayakawa H. The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension. Am J Hypertens 1: 31-37, 1988.
24. Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, and Giacca A. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Endocrinol. Metab 283: E682-E691, 2002.
25. Marwaha A, Banday AA, and Lokhandwala MF. Reduced renal dopamine D, receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 286: F451-F457, 2004.
26. Marwaha A and Lokhandwala MF. Diminished natriuretic response to dopamine D1 receptor agonist, SKF-38393 in obese Zucker rats. Clin Exp Hypertens 25: 509-515, 2003.
27. Montani JP, Antic V, Yang Z, and Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2, Suppl: S28-S38, 2002.
28. Mudaliar S and Henry RR. New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers. Annu Rev Med 52: 239-257, 2001.
29. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, and Kraegen EW. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43: 1203-1210, 1994.
30. Reaven GM. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 30: 928-931, 1997.
31. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, and Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33: 1036-1042, 1999.
32. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann NY Acad Sci 967: 146-157, 2002.
33. Schunkert H. Obesity and target organ damage: the heart. Int J Obes Relat Metab Disord 4, Suppl: S15-S20, 2002.
34. Segers O, Anckaert E, Gerlo E, Dupont AG, and Somers G. Dopamine-sodium relationship in type 2 diabetic patients. Diabetes Res Clin Pract 34: 89-98, 1996.
35. Sidhu A, Vachvanichsanong P, Jose PA, and Felder RA. Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats. J Clin Invest 89: 789-793, 1992.
36. Smith SA. Peroxisomal proliferator activated receptors (PPARs): molecular targets for hypolipidaemic agents and insulin sensitisers. Pharmacol Rev Commun 8: 57-64, 1996.
37. 1A receptor in obese Zucker rats. Hypertension 43: 376-382, 2004.
38. Uh M, White BH, and Sidhu A. Alteration of association of agonist-activated renal D1(A) dopamine receptors with G-proteins in proximal tubules of the spontaneously hypertensive rat. J Hypenens 16: 1307-1313, 1998.
39. Umrani DN, Banday AA, Hussein T, and Lokhandwala MF. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension 40: 880-885, 2002.
40. Ungerer Bohm M, Elce JS, Erdmann E, and Lohse MJ. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87: 454-463, 1993.
41. 1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 48: 9588-9594, 1995.